Chapter 55:The Unraveling

The SEC's formal notice of investigation landed on Sebastian Costa's desk at 9:47 AM, delivered by a process server in a gray suit who waited in the Costa Holdings lobby for eleven minutes while security verified his credentials. Sebastian read the document once. Then he read it again. Then he closed his office door, sat in his leather chair, and stared at the ceiling for four minutes before picking up his phone and dialing Arthur Webb. "Arthur. I just received a formal SEC notice." A pause. Webb's voice, when it came, was its usual measured baritone — unhurried, confident, the voice of a man who had been steering wealthy families through crises for thirty years. "Describe the notice." "Formal investigation into NexGen Therapeutics' Phase III clinical trial data. They're citing the NYT article, the Hunt Capital due diligence findings, and —" Sebastian flipped to the second page — "a confidential tip from a former Chesapeake Management employee regarding systematic coding irregularities in the NexGen investor disclosure materials." Webb was silent for three seconds. In the vocabulary of Arthur Webb, three seconds of silence was equivalent to a shout. "Chesapeake," he said. "That's the leak." "Chesapeake is a bookkeeping firm. It doesn't have employees with access to NexGen investor disclosures." "Chesapeake is a bookkeeping firm that I set up to manage shell company financial flows. The coding irregularities reference is someone who has seen the actual books — not the cleaned public filings, the raw internal records." Webb's voice sharpened. "Someone at Chesapeake has been inside the NexGen files." Sebastian felt something cold settle in his stomach. "Who has access to those files?" "The only person who has had access to the NexGen internal records at Chesapeake in the last year is the junior bookkeeper. Catherine Marsh." The name landed like a stone dropped into still water. Catherine Marsh. The quiet, thorough, unremarkable junior analyst who had appeared at Chesapeake seven months ago and whose work David Choi had described as "exceptionally precise." "Pull her file," Sebastian said. "Background check, employment history, references — everything." "Already done. Sterling ran a full background check before her Thorne Group transfer. It came back clean — education, employment, credit, criminal. No red flags." "Then someone missed something. Or she's better than we thought." Sebastian stood and walked to his window. Fifty-second floor. Midtown Manhattan spread below him in a grid of glass and ambition. "What's her current status?" "She transferred to Thorne Group's Corporate Strategy division six weeks ago. Level-two ThorneVault access. Healthcare sector only. No access to the restricted archive." "Six weeks." Sebastian turned from the window. "She was at Chesapeake for five months. Five months is enough time to see everything." "Sebastian. Listen to me. The SEC notice is a problem, but it's a manageable problem. NexGen is a privately held subsidiary. The investigation targets the clinical trial data, not the acquisition financing. If the SEC finds discrepancies in the trial data, the worst case is a fine and a delay in the acquisition closing. The shell company network — the financing trail — is a separate issue, and it's one the SEC has not yet connected." "Yet." "Yet. But 'yet' is not 'now.' We have time." Webb's voice shifted — the tone he used when he was about to propose something Sebastian would not like. "I think we need to accelerate the acquisition timeline. Close NexGen before the SEC investigation gains momentum. Once the deal is done, the clinical trial data becomes a post-acquisition integration issue, not a pre-closing due diligence red flag. The optics change." "Close faster? We're still $18 million short on the financing structure. The Halcyon equity line won't be ready until —" "I'll restructure. Bridge loan from Delacroix. Short-term liquidity injection. We close NexGen, absorb the SEC investigation as a portfolio company matter, and deal with the regulatory fallout after the fact." Sebastian sat down again. His fingers drummed on the armrest — a habit Leah would have recognized, had she been watching, as one of Sebastian's tells. He drummed his fingers when he was calculating risk. "And Catherine Marsh?" "I'll handle it. Quietly. I want to know who she is, where she came from, and who sent her. If she's a Hunt Capital plant, we need to know before she gets deeper into Thorne Group's internal systems." "She's already inside Thorne Group, Arthur. She's been inside for six weeks." "Then we need to know yesterday." A pause. "Sebastian. Is there any chance she's connected to Isabella?" The question hung in the air. Sebastian's drumming stopped. "Isabella is dead." "Isabella's body was never recovered. The crash was on a rural road at night. The vehicle was burned beyond recognition. Two fatalities were confirmed by dental records — the driver and a passenger. But Isabella was not in the car when it crashed. The official report says she was thrown from the vehicle. The recovery team found blood and tissue consistent with a third victim, but no identifiable remains." Sebastian's jaw tightened. "You're telling me this now?" "I'm telling you what I should have told you two years ago. I assumed you knew. I assumed Martha had told you." Webb's voice was flat. "Martha was very specific about the narrative after the crash. 'Isabella Thorne is dead. The funeral is Friday. The family is grieving. Do not ask questions.' I did not ask questions." "Because you never ask questions, Arthur. That's your job. You handle things. You don't investigate them." "And that's why you pay me. But we are now in a situation where a junior bookkeeper with a clean background check has somehow accessed enough internal information to trigger a confidential SEC tip about NexGen clinical trial data. That is not a coincidence. That is either a Hunt Capital operation or something else. And 'something else' in the context of the Thorne family usually means someone is not who they appear to be." Sebastian ended the call without saying goodbye. He sat in his office for a long time, staring at the SEC notice on his desk. Isabella. The name had not crossed his mind in months. He had buried it — along with the guilt, the shame, the specific quality of her eyes when she had looked at him across the dinner table on the night of the gala and realized, for the first time, that he had been planning her destruction since before the engagement. Isabella was dead. She had to be dead. Because if she was not dead, then everything Sebastian had built in the two years since the crash — the NexGen acquisition, the Costa Holdings expansion, the carefully constructed relationship with Martha that gave him access to the Thorne Group's financial architecture — all of it was standing on ground that could shift at any moment. He picked up the SEC notice and read the confidential tip reference a third time. *Former Chesapeake Management employee.* Not current. Former. Which meant the tip had come from someone who had left Chesapeake — or who had been positioned to leave. Kevin Marsh. Sebastian did not know the name. But Webb would find it. Webb always found it. He put the notice in his desk drawer, locked the drawer, and opened his laptop. The NexGen acquisition dashboard showed the current financing structure: $62 million committed, $18 million gap. The clinical trial data — the data that the SEC was now investigating — showed a 3.7% adverse event variance, well below the industry standard of 15-25%. The data was clean. The data was fabricated. Sebastian had known the data was fabricated when he agreed to acquire NexGen. The fabrication was the point — it made the drug appear safer and more effective than it actually was, which inflated the company's valuation, which made the acquisition a bargain, which generated returns for Costa Holdings and, through the shell company network, for Martha Thorne's trust. The fraud was the business model. And now the SEC was looking at it. He closed the laptop and called his pilot. --- Leah did not know about the SEC notice. She did not know that Sebastian Costa was sitting in his office on Fifty-Second Street, connecting the dots between a confidential tip, a junior bookkeeper, and a dead woman who might not be dead. She knew only what she could see from her desk on the thirty-fourth floor of 445 Park Avenue — which, on this particular Wednesday morning, was a lot. At 10:30 AM, David Choi called a brief meeting in the fourth-floor conference room. Present: David, Leah, Priya Sharma, and two associates from Corporate Development whom Leah had met but whose names she had filed under "not yet relevant." "Quick update," David said. "The SEC has formally notified Costa Holdings regarding an investigation into NexGen Therapeutics' clinical trial data. This is not unexpected — we've been tracking the Kerrigan article and the Hunt Capital findings. What is new is that the SEC is now treating this as a formal investigation rather than a preliminary inquiry." "Does this affect the acquisition timeline?" Priya asked. "Sebastian is pushing to accelerate the close. He wants the deal done before the investigation gains momentum. From our perspective, that means we need to complete the healthcare competitive landscape assessment and the SEC inquiry response by end of next week." Leah kept her expression neutral. Sebastian was panicking. Good. "I'll have the updated competitive landscape ready by Friday," Leah said. "Good. The SEC response is your priority, Catherine. I want the clinical data discrepancy analysis on my desk by Monday — all five discrepancies, fully sourced, with a risk assessment for each." "Understood." The meeting ended at 10:52 AM. Leah returned to her desk and opened the NexGen clinical data files in ThorneVault. She had been inside these files before — five discrepancies, all upward, one mathematically impossible. She had documented them in three memos to David, all of which he had forwarded to the SEC inquiry response team. But now the SEC was formally investigating. Which meant her memos — her careful, precise, exhaustively sourced memos — were about to become part of a federal investigation. Leah felt a quiet satisfaction that she did not allow to reach her face. --- At 12:15 PM, her phone buzzed. Encrypted channel. Ethan. *SEC formal notice to Costa Holdings. Sebastian pushing to accelerate NexGen close. Bridge loan from Delacroix to cover the $18M gap. Webb is investigating Catherine Marsh's background — specifically looking for a connection to Isabella.* Leah read the message twice. Webb was investigating Catherine Marsh. Webb was asking whether Catherine Marsh was connected to Isabella. The danger had just escalated from theoretical to concrete. *How did you get this?* she typed. *Hunt Capital has a source inside Costa Holdings legal. Webb called the GC this morning. The conversation was — let's say — overheard.* *Does the source know about me specifically?* *Not yet. Webb is running the investigation himself. He hasn't shared the Isabella theory with anyone except Sebastian, and Sebastian's reaction was — according to my source — 'sharp.'* *He suspects.* *He suspects something. He doesn't know what. The gap between suspicion and confirmation is where we operate.* Leah typed a response, then deleted it. Then typed again. *I need to accelerate the level-three clearance timeline. Sixty-one days is too long. Is there a way to get access to the restricted archive sooner?* A pause. Then: *I can request an expedited review through Hunt Capital's due diligence team. If we frame it as a necessary component of the trust structure investigation — specifically, we need to review historical trust administration records that are stored in the restricted archive — Pemberton might approve it. He's trying to clean the paper trail, not wall it off. Giving Hunt Capital access to historical records makes the trust structure look transparent.* *Do it. But make it look routine. Not targeted.* *Already drafted. I'll send it to Pemberton's office this afternoon.* Leah put down her phone. The locket pressed against her collarbone. The key sat in her pocket. The SEC notice was sitting on Sebastian's desk, and Webb was running a background investigation on Catherine Marsh, and somewhere in the building, Howard Pemberton was about to receive a request that would give Leah access to the restricted archive weeks ahead of schedule. The machine was moving. All the pieces were in motion — the SEC investigation, the Hunt Capital due diligence, the newspaper reporter, the ethics watchdog complaint, the bank access logs, the twelve names from Mount Sinai, and at the center of it all, a retired doctor in Greenwich, Connecticut, who had signed a birth certificate and received a payment and chaired the IRB that received a dead man's complaint. Leah picked up her pen and began writing. Five clinical data discrepancies. Fully sourced. Risk assessment for each. The work was the cover. The cover was the work. And behind both, the machine kept turning. --- At 5:47 PM, Leah received a ThorneVault system notification. *Access Request #2024-0412: Hunt Capital due diligence team requests expedited review of historical trust administration records (2000-2010). Requested by E. Hunt, Corporate Intelligence Division. Routing to H. Pemberton, General Counsel, for approval.* Estimated response time: 24-48 hours. Leah closed the notification and shut down her laptop. She gathered her things — coat, bag, the brass key in her pocket, the locket against her skin — and walked to the elevator. The elevator carried her to the lobby. The lobby carried her to the street. The street carried her home. In her apartment, she sat at her kitchen table and opened the Moleskine notebook — the one hidden inside the hollowed-out War and Peace. She turned to a fresh page and wrote: *April 30. Day thirty-one of Thorne Group employment.* *SEC formal investigation into NexGen.* *Webb investigating Catherine Marsh. Isabella question raised.* *Hunt Capital expedited access request to restricted archive — pending.* *IRB complaint copy incoming from ethics watchdog.* *Next: Bank access logs (First Manhattan → Heritage → Pacific National).* *Next: Martin Alvarez, NY Post.* *Next: Samuel Reinhardt, Greenwich CT.* *Timeline accelerating. Risk increasing. Cover holding.* She closed the notebook. Replaced it inside War and Peace. Set the book on the shelf. The apartment was quiet. The city hummed beyond the window. Leah touched the locket through her blouse. Inside it, two people she had never been allowed to know smiled at each other in front of a fireplace, their arms around each other, their faces unmarked by the grief that was coming. She would not let them down. She would not let any of them down.